Pfizer Conference Insights: Analyzing Bourla...

By João L. Carapinha

June 11, 2025

Pfizer CEO Albert Bourla’s discussion at the June 2025 Goldman Sachs Healthcare conference centered on Pfizer conference insights regarding the pharmaceutical industry’s evolving policy landscape, strategic priorities, and respons...
RFK Jr.’s ACIP Overhaul: Examining Vaccine Policy Implications
Elsa – FDA AI Tool: Navigating Efficiency and Ethics
The Case for Transparency in Peer Review: Enhancing Scientific Integrity and ...
BioNTech BMS Collaboration: Pioneering Advances in Solid Tumor Treatment with...
Pluvicto Prostate Cancer Trial: Phase III Results
Business Dynamics: How Novo Nordisk Lost GLP-1 Market Share
Tolebrutinib MS Analysis: Evaluating Economic Impact in SPMS
Alzheimer’s Blood Test Diagnostics: FDA Clears First Blood Test for Ear...
Another GLP-1 Drug Access Model: Will a Co-Pay Cap Revolutionize Affordability?
The Impact of MFN Pricing on the U.S. Biosimilar Market
Hepatitis Vaccine Uptake: Trends, Challenges, and the Role of Pharmacists
Biosimilars Price Competition: Impact on U.S. Pharmaceutical Pricing and Mark...